subject: Ceftriaxone: in the dumping allegations before the line - ceftriaxone - pharmaceutical industries [print this page] Ceftriaxone: in the dumping allegations before the line - ceftriaxone - pharmaceutical industries
?? 2009 full year production up by 29% Export 36.66% year on year volume growth, future growth in space can expand
Conservative, according to industry association statistics, ceftriaxone year 2009, production reached 3,768 tons, an increase of 29%, exports grew by 36.66%. In the production and export growth under way early this year has climbed to the price of ceftriaxone new heights and achieve the highest level since 2008. Entered in March, prices remained steady run.
With the increasing amount of clinical use, the output of ceftriaxone in increased export volumes also expanded. The current international trade protectionism on the rise, China Medicine Product repeated anti-dumping lawsuits, ceftriaxone is also the "victims" one. To this end, domestic manufacturers have also increased efforts to develop new export markets.
Annual growth rate of 106%, more than 40 manufacturers
Rapidly since 2000 to promote various hospitals in the country since the former occupy a large number of domestic ceftriaxone, cefazolin, cephradine and other cephalosporins old drug market share. According to statistics, cefazolin once in 1999 gross domestic cephalosporins Antibiotic Market plunged 81% to 2004 domestic Cephalosporin 41% of the market; At the same time, ceftriaxone from China in 1999 accounted for only 2.36% of cephalosporin market rose for the domestic market in 2004 accounted for 32.5%, in 2009 this proportion had increased to 43%.
Chinese Business Association, according to statistics, over the past few years, in our country ceftriaxone, cefazolin, cefotaxime, cefoperazone, cefuroxime and ceftazidime in the six largest output of cephalosporins, only ceftriaxone The annual growth rate of 106%, the highest growth rate in the first cephalosporin.
The earliest access to ceftriaxone API Approval of the enterprises producing the Northeast Pharmacy Factory, Beijing Zizhu Pharmaceutical and Southwest Synthetic Pharmaceutical Factory 3. However, as of 2009, domestic production of raw drug ceftriaxone has increased to more than 40 manufacturers. Larger enterprises which yield Hill Xi Weiqi Yongda, Fuzhou antibiotic medicine, Yue Hong medicine, Shanghai Pioneer Pharmaceutical, Livzon Pharmaceutical shares, Zhuhai Yue state pharmaceutical, Qilu An 10 for the pharmaceutical, production Domestic production accounts for approximately 80% of ceftriaxone.
Troubled anti-dumping litigation, uncertainties increase Cephalosporin bulk drugs and other major difference is that for the domestic market, China exports a large ceftriaxone. Over the past few years the number of domestic exports of bulk drugs ceftriaxone has been the country's total output of 3 to 4 percent. In 2008, China exported about 900 tonnes of bulk drug ceftriaxone, of which only the number of India's exports of ceftriaxone meal that is up to more than 400 tons, accounting for China's exports about half of ceftriaxone API.
Ceftriaxone main export market of China for India, Korea, Europe, Latin America and Southeast Asia. It is noteworthy that the higher production costs in Europe and the market as Sell Reduce the number of other factors, have rarely produced ceftriaxone cephalosporins, change of imports from China, so China in recent years, exports to Europe ceftriaxone increased year by year. Even Italy and Spain, the production of cephalosporin and other traditional powers, China began to import bulk drugs used in the production of ceftriaxone formulations.
Promising export market and as ceftriaxone, higher profits, in turn, stimulated the production capacity in China ceftriaxone API further expansion. However, the actual capacity of the domestic market at a faster rate of digestion can not increase production, eventually leading to ceftriaxone rushed meal in bulk exports, India, Europe and other markets, causing a number of countries immediately launched by the Chinese anti-dumping lawsuits ceftriaxone.
Government of India Commerce and Industry in October 2008 a formal decision of dumping of Chinese exports of coarse behavior ceftriaxone, and ceftriaxone in our four main producers and exporters are subject to 108% and 120% anti-dumping duties.
